These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Clinical, biochemical and genetic approaches to the detection of familial hyperaldosteronism type I. Stowasser M, Bachmann AW, Jonsson JR, Tunny TJ, Klemm SA, Gordon RD. J Hypertens; 1995 Dec 23; 13(12 Pt 2):1610-3. PubMed ID: 8903619 [Abstract] [Full Text] [Related]
34. Selection of patients for surgery for primary aldosteronism. Plouin PF, Rossignol P, Amar L. Clin Exp Pharmacol Physiol; 2008 Apr 14; 35(4):522-5. PubMed ID: 18307754 [Abstract] [Full Text] [Related]
35. [Some indices of the functional state of the adrenal cortex and electrolyte metabolism in primary arterial hypotension]. Rudoĭ BD. Kardiologiia; 1971 May 14; 11(5):110-4. PubMed ID: 4331228 [No Abstract] [Full Text] [Related]
39. Effect of spironolactone on fluid volumes and adrenal steroids in primary aldosteronism. Ichikawa S, Tajima Y, Sakamaki T, Matsuo H, Kogure M, Hirano Y, Yagi S, Murata K. Jpn Circ J; 1984 Nov 14; 48(11):1184-96. PubMed ID: 6502914 [Abstract] [Full Text] [Related]
40. [Steroid spirolactones--antagonists of mineralocorticoids]. Linèt O. Cesk Farm; 1969 Jun 14; 18(4):218-26. PubMed ID: 4895579 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]